SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveillance

NCT07503717 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
HER2-Positive Metastatic Breast Cancer

Interventions

DIAGNOSTIC_TEST: Brain Magnetic Resonance Imaging (MRI) with Contrast

Sponsor

Royal College of Surgeons, Ireland

Collaborators

[object Object]
[object Object]